Transgender Women Benefit from Prostate Cancer Screenings
Transgender women keep their prostates even after gender-affirming surgery, and the estimated risk of prostate cancer is at about 14 cases per 10,000 people.
University of California San Francisco
Give to UCSF
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.
UCSF Improves Care Options for Metastatic Gastrointestinal Cancer
UCSF's Division of Surgical Oncology is currently the only center in Northern California offering surgical insertion of hepatic artery infusion (HAI) for patients.
Drug Resistance, Targeted Cell Therapies Among Cancer Conference Talks
Leading cancer researchers from UCSF will present at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 14-19, 2023, in Orlando.
Thermo Fisher Scientific Opens Cell Therapy Facility at UCSF to Accelerate Development of Breakthrough Therapies
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
Can Lymph Nodes Boost the Success of Cancer Immunotherapy?
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
California’s Anti-Smoking Push Spurs Big Savings on Health Costs
For the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.
New App Calculates Women’s Risk for Advanced Breast Cancer
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
Paid Sick Leave Means More People Get Screened for Cancer
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
Science World Honors Kevan Shokat for High-Impact Cancer Research
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
If Immunity Is Innate, What Impacts Our Ability to Fight Infections?
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
